Market & Economy News

Hong Kong Authorizes Sinovac Vaccine for Children Aged 3-17

HONG KONG — Hong Kong has approved lowering the age limit for the COVID-19 vaccine from China’s Sinovac Biotech to three years old, down from 18 years of age, as it pursues a broader campaign to incentivise its 7.5 million residents to get vaccinated. Read More